KBC Group
CDMO

KBC Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

KBC Group’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,739
Closed -$26K – 1914
2023
Q3 		$26K Sell
2,739
-1,852
-40% -$22.3K ﹤0.01% 1847
2023
Q2 		$64K Sell
4,591
-793
-15% -$13.5K ﹤0.01% 1304
2023
Q1 		$101K Hold
5,384
– – ﹤0.01% 1200
2022
Q4 		$74K Hold
5,384
– – ﹤0.01% 1305
2022
Q3 		$103K Hold
5,384
– – ﹤0.01% 1178
2022
Q2 		$82K Buy
+5,384
New +$79.6K ﹤0.01% 1296

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

KBC Group's CDMO Position: Q4 2023 in Review

KBC Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2023, closing a stake of 2,739 shares — an estimated $26K sold.

KBC Group first reported a position in CDMO in Q2 2022 and held it in 6 quarters. The position peaked at $103K in Q3 2022. 174 funds tracked by Wall St. Rank hold CDMO as of Q4 2023.

  • KBC Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • KBC Group sold 2,739 Avid Bioservices, Inc. Common Stock shares in Q4 2023, an estimated $26K.
  • KBC Group first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2022 and held it in 6 quarters.
  • KBC Group's Avid Bioservices, Inc. Common Stock position peaked at $103K in Q3 2022.
  • 174 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2023.

Based on KBC Group's 13F filing for Q4 2023, filed 13 Feb 2024.